학술논문

CD34+ progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rgnull mice
Document Type
Article
Source
In: OncoImmunology. (OncoImmunology, 2021, 10(1))
Subject
Language
English
ISSN
2162402X
21624011